SUI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
SUI is not a good buy right now for an impatient investor. The technicals are only mildly bullish and the stock is sitting just below nearby resistance (129–131), while fundamentals from the latest reported quarter show a sharp profitability collapse (EPS and net income down ~97% YoY). With no proprietary buy signals, neutral hedge-fund/insider activity, and options positioning leaning defensive (puts > calls), the risk/reward for buying immediately is not compelling. A hold/wait stance is more appropriate ahead of the Feb-23 earnings catalyst.
Price is trading around 127.43 post-market, slightly above the pivot (126.754), which is mildly constructive. MACD histogram is positive (0.0781) and expanding, suggesting improving momentum, but RSI(6) at ~56.7 is neutral (no strong overbought/oversold edge). Moving averages are converging, consistent with a consolidation/transition rather than a clean trend. Key levels: support at 126.75 then 124.22/122.66; resistance at 129.29 then 130.85. With price close to resistance and only moderate momentum, upside appears capped near-term unless a catalyst breaks the range. Pattern-based outlook also implies mild weakness next day/week (-0.46% / -1.73%) before a better 1-month bias (+3.78%).
Analyst tone has pockets of optimism: Deutsche Bank upgraded to Buy with a $145 target (Jan-20), and several firms maintain Buy/Overweight ratings with targets mostly above the current price.
Upcoming earnings (QDEC
on 2026-02-23 after hours can reset expectations if profitability rebounds (EPS est. 1.37).
Technical setup is not bearish: price above pivot with positive MACD suggests potential for a grind higher if it clears 129–131.
Latest quarter profitability deterioration is severe: 2025/Q3 net income and EPS down ~97% YoY, which can keep a lid on the stock until visibility improves.
Options open interest skew (P/C 1.
leans defensive rather than bullish.
Near-term technical overhead supply: resistance concentrated at ~129.3 and ~130.85; buying just under resistance is unattractive for an impatient entry.
News items provided are about crypto (XRP/Sui blockchain) and do not appear to be direct catalysts for Sun Communities (SUI), reducing the usefulness of the current news flow for this ticker.
Latest reported quarter: 2025/Q3. Revenue rose to $697.2M (+2.47% YoY), showing modest top-line growth. However, net income fell to $8.5M (-97.06% YoY) and EPS to $0.07 (-97.00% YoY), indicating a major drop in profitability/earnings power. Gross margin improved to 38.01% (+6.74% YoY), which is a positive operating signal, but the earnings collapse dominates the near-term fundamental picture until management demonstrates a sustained rebound.
Recent trend: targets have generally been nudged up/down modestly, with ratings mixed but slightly constructive overall. Notable changes: Deutsche Bank upgraded to Buy with a $145 PT (Jan-20). UBS maintained Neutral and nudged PT to $127 (Jan-08). Morgan Stanley kept Equal Weight and lowered PT to $135 (Nov-25). Barclays reiterated Overweight and raised PT to $143 (Nov-25). Truist reiterated Buy and raised PT to $142 (Nov-18). Baird stayed Neutral with PT $136 (Nov-19). Wall Street pros: (a) multiple Buy/Overweight ratings with upside to the low/mid-140s, (b) expectation for improving REIT conditions and return to growth. Cons: (a) several major firms remain Neutral/Equal Weight, implying limited conviction, (b) mixed target revisions suggest the story isn’t clean, and (c) the latest quarter’s earnings weakness makes the bull case more dependent on a forward rebound. Politicians/congress trading: no recent congress trading data available; hedge funds and insiders are reported as neutral with no significant recent trend.
